Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
If a product is approved in the future, any transition would depend on the label, safety history, other medicines, and clinician judgment
The lack of a single target has made DSIP harder to develop as a pharmaceutical, but the same versatility is partly why it has attracted research interest across different therapeutic areas
Attia SM, et al
Educational Example: How Dilution Affects Doses Imagine a 10mg vial of Retatrutide reconstituted with 1mL of bacteriostatic water
US$ 26.55
US$ 23.66
US$ 25.15
US$ 25.57
US$ 29.83
